You just read:

Upsher-Smith Presents Data Characterizing The Pharmacokinetics And Safety/Tolerability Of Investigational Midazolam Nasal Spray (USL261) In Pediatric Participants With Epilepsy

News provided by

Upsher-Smith Laboratories, Inc.

28 Oct, 2016, 09:00 ET